The DOI matches its Crossref record; 306 of the 306 references it cites were found in a registry or an index.
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
Open accessAbstract
Adrenocortical carcinoma (ACC) is a rare and in most cases steroid hormone-producing tumor with variable prognosis. The purpose of these guidelines is to provide clinicians with best possible evidence-based recommendations for clinical management of patients with ACC based on the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. We predefined four main clinical questions, which we judged as particularly important for the management of ACC patients and performed systematic literature searches: (A) What is needed to diagnose an ACC by histopathology? (B) Which are the best prognostic markers in ACC? (C) Is adjuvant therapy able to prevent recurrent disease or reduce mortality after radical resection? (D) What is the best treatment option for macroscopically incompletely resected, recurrent or metastatic disease? Other relevant questions were discussed within the group. Selected Recommendations: (i) We recommend that all patients with suspected and proven ACC are discussed in a multidisciplinary expert team meeting. (ii) We recommend that every patient with (suspected) ACC should undergo careful clinical assessment, detailed endocrine work-up to identify autonomous hormone excess and adrenal-focused imaging. (iii) We recommend that adrenal surgery for (suspected) ACC should be performed only by surgeons experienced in adrenal and oncological surgery aiming at a complete en bloc resection (including resection of oligo-metastatic disease). (iv) We suggest that all suspected ACC should be reviewed by an expert adrenal pathologist using the Weiss score and providing Ki67 index. (v) We suggest adjuvant mitotane treatment in patients after radical surgery that have a perceived high risk of recurrence (ENSAT stage III, or R1 resection, or Ki67 >10%). (vi) For advanced ACC not amenable to complete surgical resection, local therapeutic measures (e.g. radiation therapy, radiofrequency ablation, chemoembolization) are of particular value. However, we suggest against the routine use of adrenal surgery in case of widespread metastatic disease. In these patients, we recommend either mitotane monotherapy or mitotane, etoposide, doxorubicin and cisplatin depending on prognostic parameters. In selected patients with a good response, surgery may be subsequently considered. (vii) In patients with recurrent disease and a disease-free interval of at least 12 months, in whom a complete resection/ablation seems feasible, we recommend surgery or alternatively other local therapies. Furthermore, we offer detailed recommendations about the management of mitotane treatment and other supportive therapies. Finally, we suggest directions for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4061 · Cited by 2,925
Prognostic significance of morphologic parameters in renal cell carcinoma
Fuhrman, S. A., Lasky, L. C., & Limas, C. (1982) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198210000-00007 · Cited by 2,724
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
Ferrell, B. R., Temel, J. S., Temin, S., Alesi, E. R., Balboni, T. A., Basch, E. M., Firn, J. I., Paice, J. A., Peppercorn, J. M., Phillips, T., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.1474 · Cited by 2,117
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769
Immortal Time Bias in Pharmacoepidemiology
Suissa, S. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwm324 · Cited by 1,708
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566
Self-citationAndrews, J., Guyatt, G., Oxman, A. D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P. N., Kunz, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.03.013 · Cited by 1,416
Andrews, J. C., Schünemann, H. J., Oxman, A. D., Pottie, K., Meerpohl, J. J., Coello, P. A., Rind, D., Montori, V. M., Brito, J. P., Norris, S., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.003 · Cited by 1,315
Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
Instruments for Causal Inference: An Epidemiologist's Dream?
Hernán, M. A., & Robins, J. M. (2006) · Epidemiology · doi:10.1097/01.ede.0000222409.00878.37 · Cited by 961
Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors
Weiss, L. M. (1984) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198403000-00001 · Cited by 920
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
Self-citationCombination Chemotherapy in Advanced Adrenocortical Carcinoma
Fassnacht, M., Terzolo, M., Allolio, B., Baudin, E., Haak, H., Berruti, A., Welin, S., Schade-Brittinger, C., Lacroix, A., Jarzab, B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200966 · Cited by 873
Self-citationPathologic features of prognostic significance in adrenocortical carcinoma
Weiss, L. M., Medeiros, L. J., & Vickery, A. L. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198903000-00004 · Cited by 818
Adrenocortical Carcinoma: Clinical Update
Allolio, B., & Fassnacht, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2639 · Cited by 775
Self-citationAdjuvant Mitotane Treatment for Adrenocortical Carcinoma
Terzolo, M., Angeli, A., Fassnacht, M., Daffara, F., Tauchmanova, L., Conton, P. A., Rossetto, R., Buci, L., Sperone, P., Grossrubatscher, E., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063360 · Cited by 764
Self-citationIntegrated genomic characterization of adrenocortical carcinoma
Assié, G., Letouzé, E., Fassnacht, M., Jouinot, A., Luscap, W., Barreau, O., Omeiri, H., Rodriguez, S., Perlemoine, K., René-Corail, F., et al. (2014) · Nature Genetics · doi:10.1038/ng.2953 · Cited by 732
Self-citationSystematic review and meta-analysis of psychological therapies for children with chronic pain
Fisher, E., Heathcote, L., Palermo, T. M., de C Williams, A. C., Lau, J., & Eccleston, C. (2014) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsu008 · Cited by 710
Fassnacht, M., Johanssen, S., Quinkler, M., Bucsky, P., Willenberg, H. S., Beuschlein, F., Terzolo, M., Mueller, H., Hahner, S., Allolio, B., et al. (2009) · Cancer · doi:10.1002/cncr.24030 · Cited by 695
Self-citationAdrenal Masses: Characterization with Combined Unenhanced and Delayed Enhanced CT
Caoili, E. M., Korobkin, M., Francis, I. R., Cohan, R. H., Platt, J. F., Dunnick, N. R., & Raghupathi, K. I. (2002) · Radiology · doi:10.1148/radiol.2223010766 · Cited by 690
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., Lerario, A. M., Else, T., Knijnenburg, T. A., Ciriello, G., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.002 · Cited by 657
Self-citationNCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
Daly, M. B., Pilarski, R., Berry, M., Buys, S. S., Farmer, M., Friedman, S., Garber, J. E., Kauff, N. D., Khan, S., Klein, C., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0003 · Cited by 650
Icard, P., Goudet, P., Charpenay, C., Andreassian, B., Carnaille, B., Chapuis, Y., Cougard, P., Henry, J., & Proye, C. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0047-y · Cited by 543
Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome
Kratz, C. P., Achatz, M. I., Brugières, L., Frebourg, T., Garber, J. E., Greer, M.-L. C., Hansford, J. R., Janeway, K. A., Kohlmann, W. K., McGee, R., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0408 · Cited by 534
Adrenocortical carcinoma in the United States: Treatment utilization and prognostic factors
Bilimoria, K. Y., Shen, W. T., Elaraj, D., Bentrem, D. J., Winchester, D. J., Kebebew, E., & Sturgeon, C. (2008) · Cancer · doi:10.1002/cncr.23886 · Cited by 493
Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours
Lam, A. K.-Y. (2017) · Endocrine Pathology · doi:10.1007/s12022-017-9484-5 · Cited by 462
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
Arlt, W., Biehl, M., Taylor, A. E., Hahner, S., Libé, R., Hughes, B. A., Schneider, P., Smith, D. J., Stiekema, H., Krone, N., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1565 · Cited by 458
Self-citationExtent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?
Kebebew, E., Reiff, E., Duh, Q., Clark, O. H., & McMillan, A. (2006) · World Journal of Surgery · doi:10.1007/s00268-005-0329-x · Cited by 451
Abiven, G., Coste, J., Groussin, L., Anract, P., Tissier, F., Legmann, P., Dousset, B., Bertagna, X., & Bertherat, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2730 · Cited by 435
Update in Adrenocortical Carcinoma
Fassnacht, M., Kroiss, M., & Allolio, B. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3020 · Cited by 414
Self-citationAdrenocortical carcinoma: a clinician’s update
Fassnacht, M., Libé, R., Kroiss, M., & Allolio, B. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.235 · Cited by 396
Bosco, J. L. F., Silliman, R. A., Thwin, S. S., Geiger, A. M., Buist, D. S. M., Prout, M. N., Yood, M. U., Haque, R., Wei, F., & Lash, T. L. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.03.001 · Cited by 394
Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis
Giordano, T. J., Thomas, D. G., Kuick, R., Lizyness, M., Misek, D. E., Smith, A. L., Sanders, D., Aljundi, R. T., Gauger, P. G., Thompson, N. W., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63846-1 · Cited by 383
de Reyniès, A., Assié, G., Rickman, D. S., Tissier, F., Groussin, L., René-Corail, F., Dousset, B., Bertagna, X., Clauser, E., & Bertherat, J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.5678 · Cited by 382
Self-citationAubert, S., Wacrenier, A., Leroy, X., Devos, P., Carnaille, B., Proye, C., Wemeau, J. L., Lecomte-Houcke, M., & Leteurtre, E. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200212000-00009 · Cited by 378
Stoffel, E. M., Mangu, P. B., Gruber, S. B., Hamilton, S. R., Kalady, M. F., Lau, M. W. Y., Lu, K. H., Roach, N., & Limburg, P. J. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.1322 · Cited by 373
Schulick, R. D., & Brennan, M. F. (1999) · Annals of Surgical Oncology · doi:10.1007/s10434-999-0719-7 · Cited by 366
Clinical management of adrenocortical carcinoma
Fassnacht, M., & Allolio, B. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.008 · Cited by 349
Major Prognostic Role of Ki67 in Localized Adrenocortical Carcinoma After Complete Resection
Beuschlein, F., Weigel, J., Saeger, W., Kroiss, M., Wild, V., Daffara, F., Libé, R., Ardito, A., Al Ghuzlan, A., Quinkler, M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3182 · Cited by 342
Self-citationKerkhofs, T. M. A., Verhoeven, R. H. A., Van der Zwan, J. M., Dieleman, J., Kerstens, M. N., Links, T. P., Van de Poll-Franse, L. V., & Haak, H. R. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.02.034 · Cited by 341
Self-citationFassnacht, M., Berruti, A., Baudin, E., Demeure, M. J., Gilbert, J., Haak, H., Kroiss, M., Quinn, D. I., Hesseltine, E., Ronchi, C. L., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70081-1 · Cited by 339
Self-citationAdrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Berruti, A., Baudin, E., Gelderblom, H., Haak, H. R., Porpiglia, F., Fassnacht, M., & Pentheroudakis, G. (2012) · Annals of Oncology · doi:10.1093/annonc/mds231 · Cited by 331
Self-citationHaak, H., Hermans, J., van de Velde, C., Lentjes, E., Goslings, B., Fleuren, G.-J., & Krans, H. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.183 · Cited by 329
Self-citationMorphologic characteristics of benign and malignant adrenocortical tumors
Slooten, H. V., Schaberg, A., Smeenk, D., & Moolenaar, A. J. (1985) · Cancer · doi:10.1002/1097-0142(19850215)55:4<766::aid-cncr2820550414>3.0.co;2-7 · Cited by 326
Adrenocortical Oncocytic Tumors: Report of 10 Cases and Review of the Literature
Bisceglia, M., Ludovico, O., Di Mattia, A., Ben-Dor, D., Sandbank, J., Pasquinelli, G., Lau, S. K., & Weiss, L. M. (2004) · International Journal of Surgical Pathology · doi:10.1177/106689690401200304 · Cited by 318
Berruti, A., Terzolo, M., Sperone, P., Pia, A., Della Casa, S., Gross, D. J., Carnaghi, C., Casali, P., Porpiglia, F., Mantero, F., et al. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01025 · Cited by 308
Self-citationCawood, T. J., Hunt, P. J., O'Shea, D., Cole, D., & Soule, S. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0234 · Cited by 300
Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center
Ayala-Ramirez, M., Jasim, S., Feng, L., Ejaz, S., Deniz, F., Busaidy, N., Waguespack, S. G., Naing, A., Sircar, K., Wood, C. G., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0519 · Cited by 293
Gicquel, C., BERTAGNA, X. Y., Gaston, V., Coste, J., Louvel, A., Baudin, É., Bertherat, J. Y., Chapuis, Y., Duclos, J. M., Schlumberger, M. J., et al. (2001) · PubMed · Cited by 285
Adrenocortical cancer: pathophysiology and clinical management
Libè, R., Fratticci, A., & Bertherat, J. (2007) · Endocrine-Related Cancer · doi:10.1677/erc.1.01130 · Cited by 272
The optimal imaging of adrenal tumours: a comparison of different methods
Ilias, I., Sahdev, A., Reznek, R. H., Grossman, A. B., & Pacak, K. (2007) · Endocrine-Related Cancer · doi:10.1677/erc-07-0045 · Cited by 266
Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases
Wood, B. J., Abraham, J., Hvizda, J. L., Alexander, H. R., & Fojo, T. (2003) · Cancer · doi:10.1002/cncr.11084 · Cited by 264
Macfarlane, D. A. (1958) · PubMed · Cited by 263
Libé, R., Borget, I., Ronchi, C. L., Zaggia, B., Kroiss, M., Kerkhofs, T., Bertherat, J., Volante, M., Quinkler, M., Chabre, O., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv329 · Cited by 263
Self-citationEfficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma
Fassnacht, M., Hahner, S., Polat, B., Koschker, A.-C., Kenn, W., Flentje, M., & Allolio, B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1007 · Cited by 259
Blake, M. A., Kalra, M. K., Sweeney, A. T., Lucey, B. C., Maher, M. M., Sahani, D. V., Halpern, E. F., Mueller, P. R., Hahn, P. F., & Boland, G. W. (2006) · Radiology · doi:10.1148/radiol.2382041514 · Cited by 258
Sullan, M., Boileau, M., & Hodges, C. V. (1978) · Journal of Urology · doi:10.1016/s0022-5347(17)57317-6 · Cited by 255
Crucitti, F., Bellantone, R., Ferrante, A., Boscherini, M., & Crucitti, P. (1996) · Surgery · doi:10.1016/s0039-6060(96)80164-4 · Cited by 247
Baudin, E., Pellegriti, G., Bonnay, M., Penfornis, A., Laplanche, A., Vassal, G., & Schlumberger, M. (2001) · Cancer · doi:10.1002/1097-0142(20010915)92:6<1385::aid-cncr1461>3.0.co;2-2 · Cited by 239
Self-citationBusam, K. J., Iversen, K., Coplan, K. A., Old, L. J., Stockert, E., Chen, Y.-T., McGregor, D., & Jungbluth, A. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199801000-00007 · Cited by 238
Prognostic parameters of metastatic adrenocortical carcinoma
Assié, G., Antoni, G., Tissier, F., Caillou, B., Abiven, G., Gicquel, C., Leboulleux, S., Travagli, J.-P., Dromain, C., Bertagna, X., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0706 · Cited by 236
Wasserman, J. D., Novokmet, A., Eichler-Jonsson, C., Ribeiro, R. C., Rodriguez-Galindo, C., Zambetti, G. P., & Malkin, D. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.6863 · Cited by 227
Gaujoux, S., Mihai, R., Carnaille, B., Dousset, B., Fiori, C., Porpiglia, F., Hellman, P., Iacobone, M., Kraimps, J.-L., Donatini, G., et al. (2017) · British Journal of Surgery · doi:10.1002/bjs.10414 · Cited by 226
Self-citationGicquel, C. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.6.1444 · Cited by 224
Groussin, L., Bonardel, G., Silvéra, S., Tissier, F., Coste, J., Abiven, G., Libé, R., Bienvenu, M., Alberini, J.-L., Salenave, S., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2302 · Cited by 215
Lughezzani, G., Sun, M., Perrotte, P., Jeldres, C., Alasker, A., Isbarn, H., Budäus, L., Shariat, S. F., Guazzoni, G., Montorsi, F., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.12.007 · Cited by 215
Bellantone, R., Ferrante, A., Boscherini, M., Lombardi, C. P., Crucitti, P., Crucitti, F., Favia, G., Borrelli, D., Boffi, L., Capussotti, L., et al. (1997) · Surgery · doi:10.1016/s0039-6060(97)90229-4 · Cited by 210
Adrenocortical carcinoma is a Lynch syndrome-associated cancer
Raymond, V. M., Everett, J. N., Furtado, L. V., Gustafson, S. L., Jungbluth, C. R., Gruber, S. B., Hammer, G. D., Stoffel, E. M., Greenson, J. K., Giordano, T. J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.0988 · Cited by 208
Self-citationPark, H. S. (2009) · Archives of Surgery · doi:10.1001/archsurg.2009.191 · Cited by 201
Boulle, N., Logié, A., Gicquel, C., Périn, L., & Bouc, Y. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4816 · Cited by 201
Guideline panels should not GRADE good practice statements
Guyatt, G. H., Schünemann, H. J., Djulbegovic, B., & Akl, E. A. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.12.011 · Cited by 201
Else, T., Williams, A. R., Sabolch, A., Jolly, S., Miller, B. S., & Hammer, G. D. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2856 · Cited by 201
Self-citationCustódio, G., Parise, G. A., Kiesel Filho, N., Komechen, H., Sabbaga, C. C., Rosati, R., Grisa, L., Parise, I. Z. S., Pianovski, M. A. D., Fiori, C. M. C. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3711 · Cited by 201
van Slooten, H., Moolenaar, A. J., van Seter, A. P., & Smeenk, D. (1984) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(84)90033-6 · Cited by 198
Haluska, P., Worden, F., Olmos, D., Yin, D., Schteingart, D., Batzel, G. N., Paccagnella, M. L., de Bono, J. S., Gualberto, A., & Hammer, G. D. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1083-9 · Cited by 197
Sturgeon, C., Shen, W. T., Clark, O. H., Duh, Q.-Y., & Kebebew, E. (2006) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2005.11.005 · Cited by 194
Sbiera, S., Leich, E., Liebisch, G., Sbiera, I., Schirbel, A., Wiemer, L., Matysik, S., Eckhardt, C., Gardill, F., Gehl, A., et al. (2015) · Endocrinology · doi:10.1210/en.2015-1367 · Cited by 191
Self-citationRadiotherapy in adrenocortical carcinoma
Polat, B., Fassnacht, M., Pfreundner, L., Guckenberger, M., Bratengeier, K., Johanssen, S., Kenn, W., Hahner, S., Allolio, B., & Flentje, M. (2009) · Cancer · doi:10.1002/cncr.24331 · Cited by 189
Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients
Chabre, O., Libé, R., Assie, G., Barreau, O., Bertherat, J., Bertagna, X., Feige, J.-J., & Cherradi, N. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-13-0051 · Cited by 189
Self-citationKhan, T. S., Imam, H., Juhlin, C., Skogseid, B., Gröndal, S., Tibblin, S., Wilander, E., Öberg, K., & Eriksson, B. (2000) · Annals of Oncology · doi:10.1023/a:1008377915129 · Cited by 183
Faßnacht, M., Johanssen, S., Fenske, W. K., Weismann, D., Agha, A., Beuschlein, F., Führer, D., Jurowich, C. F., Quinkler, M. O., Petersenn, S., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0803 · Cited by 183
Ballinger, M. L., Best, A., Mai, P. L., Khincha, P. P., Loud, J. T., Peters, J. A., Achatz, M. I., Chojniak, R., Balieiro da Costa, A., Santiago, K. M., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.1968 · Cited by 180
Juhlin, C. C., Goh, G., Healy, J. M., Fonseca, A. L., Scholl, U. I., Stenman, A., Kunstman, J. W., Brown, T. C., Overton, J. D., Mane, S. M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3282 · Cited by 178
Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma
Reibetanz, J., Jurowich, C., Erdogan, I., Nies, C., Rayes, N., Dralle, H., Behrend, M., Allolio, B., & Fassnacht, M. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e3182367ac3 · Cited by 176
Almeida, M. Q., Fragoso, M. C. B. V., Lotfi, C. F. P., Santos, M. G., Nishi, M. Y., Costa, M. H. S., Lerario, A. M., Maciel, C. C., Mattos, G. E., Jorge, A. A. L., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0065 · Cited by 176
Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trial
Kroiss, M., Quinkler, M., Johanssen, S., van Erp, N. P., Lankheet, N., Pöllinger, A., Laubner, K., Strasburger, C. J., Hahner, S., Müller, H.-H., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1419 · Cited by 175
Hermsen, I. G., Fassnacht, M., Terzolo, M., Houterman, S., den Hartigh, J., Leboulleux, S., Daffara, F., Berruti, A., Chadarevian, R., Schlumberger, M., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2676 · Cited by 173
Self-citationLeboulleux, S., Dromain, C., Bonniaud, G., Aupérin, A., Caillou, B., Lumbroso, J., Sigal, R., Baudin, E., & Schlumberger, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1540 · Cited by 170
Self-citationSperone, P., Ferrero, A., Daffara, F., Priola, A., Zaggia, B., Volante, M., Santini, D., Vincenzi, B., Badalamenti, G., Intrivici, C., et al. (2010) · Endocrine-Related Cancer · doi:10.1677/erc-09-0281 · Cited by 167
Self-citationProspective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly
Daffara, F., De Francia, S., Reimondo, G., Zaggia, B., Aroasio, E., Porpiglia, F., Volante, M., Termine, A., Di Carlo, F., Dogliotti, L., et al. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0103 · Cited by 167
Self-citationTreatment of Advanced Adrenocortical Carcinoma with Erlotinib plus Gemcitabine
Quinkler, M. O., Hahner, S., Wortmann, S., Johanssen, S., Adam, P., Ritte, C., Strasburger, C. J., Allolio, B., & Faßnacht, M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2564 · Cited by 166
Merits and pitfalls of mifepristone in Cushing's syndrome
Castinetti, F., Fassnacht, M., Johanssen, S., Terzolo, M., Bouchard, P., Chanson, P., Do Cao, C., Morange, I., Picó, A., Ouzounian, S., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0098 · Cited by 163
Self-citationGrubbs, E. G., Callender, G. G., Xing, Y., Perrier, N. D., Evans, D. B., Phan, A. T., & Lee, J. E. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0716-x · Cited by 158
Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer
Berruti, A., Fassnacht, M., Haak, H., Else, T., Baudin, E., Sperone, P., Kroiss, M., Kerkhofs, T., Williams, A. R., Ardito, A., et al. (2014) · European Urology · doi:10.1016/j.eururo.2013.11.006 · Cited by 158
Self-citationMitotane for adrenocortical carcinoma treatment.
Hahner, S., & Faßnacht, M. (2005) · PubMed · Cited by 156
The role of surgery in the management of recurrent adrenocortical carcinoma
Erdogan, I., Deutschbein, T., Jurowich, C., Kroiss, M., Ronchi, C., Quinkler, M., Waldmann, J., Willenberg, H. S., Beuschlein, F., Fottner, C., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2559 · Cited by 154
Chortis, V., Taylor, A. E., Schneider, P., Tomlinson, J. W., Hughes, B. A., O'Neil, D. M., Libé, R., Allolio, B., Bertagna, X., Bertherat, J., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2851 · Cited by 154
Self-citationAdrenal tumors: How to establish malignancy?
Faßnacht, M., Kenn, W., & Allolio, B. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03351068 · Cited by 151
Kroiss, M., Quinkler, M., Lutz, W. K., Allolio, B., & Fassnacht, M. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04214.x · Cited by 148
Self-citationNaing, A., LoRusso, P. M., Fu, S., Hong, D. S., Chen, H. X., Doyle, L. A., Phan, A. T., Habra, M. A., & Kurzrock, R. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.46 · Cited by 147
Berruti, A., Sperone, P., Ferrero, A., Germano, A., Ardito, A., Priola, A. M., Francia, S. D., Volante, M., Daffara, F., Generali, D., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0918 · Cited by 146
Self-citationBerruti, A., Grisanti, S., Pulzer, A., Claps, M., Daffara, F., Loli, P., Mannelli, M., Boscaro, M., Arvat, E., Tiberio, G. A. M., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2894 · Cited by 146
Self-citationBancos, I., Tamhane, S., Shah, M., Delivanis, D. A., Alahdab, F., Arlt, W., Fassnacht, M., & Murad, M. H. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0297 · Cited by 144
Terzolo, M. (1997) · Archives of Surgery · doi:10.1001/archsurg.1997.01430320116020 · Cited by 143
Self-citationWong, D., Spagnolo, D. V., Bisceglia, M., Havlat, M. F., McCallum, D., & Platten, M. A. (2011) · Human Pathology · doi:10.1016/j.humpath.2010.08.010 · Cited by 141
MORIMOTO, R., SATOH, F., MURAKAMI, O., SUZUKI, T., ABE, T., TANEMOTO, M., ABE, M., URUNO, A., ISHIDOYA, S., ARAI, Y., et al. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07-079 · Cited by 141
Mitotane Monotherapy in Patients With Advanced Adrenocortical Carcinoma
Megerle, F., Herrmann, W., Schlötelburg, W., Ronchi, C. L., Pulzer, A., Quinkler, M. O., Beuschlein, F., Hahner, S., Kroiß, M., Faßnacht, M., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02591 · Cited by 140
Chiche, L., Dousset, B. E., Kieffer, É., & Chapuis, Y. (2005) · Surgery · doi:10.1016/j.surg.2005.05.014 · Cited by 137
Kim, Y., Margonis, G. A., Prescott, J. D., Tran, T. B., Postlewait, L. M., Maithel, S. K., Wang, T. S., Evans, D. B., Hatzaras, I. S., Shenoy, R. S., et al. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2015.4516 · Cited by 136
Donatini, G., Caiazzo, R. J., Cao, C. D., Aubert, S., Zerrweck, C., El-Kathib, Z., Gauthier, T., Leteurtre, E., Wémeau, J.-L., Vantyghem, M., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3164-6 · Cited by 135
Terzolo, M., Baudin, A. E., Ardito, A., Kroiss, M., Leboulleux, S., Daffara, F., Perotti, P., Feelders, R. A., deVries, J. H., Zaggia, B., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0242 · Cited by 134
Self-citationBevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma
Wortmann, S., Quinkler, M., Ritter, C., Kroiss, M., Johanssen, S., Hahner, S., Allolio, B., & Fassnacht, M. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0804 · Cited by 133
Seccia, T. M., Fassina, A., Nussdorfer, G. G., Pessina, A. C., & Rossi, G. P. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00867 · Cited by 131
Androgen Replacement Therapy: Present and Future
Gooren, L. J., & Bunck, M. C. M. (2004) · Drugs · doi:10.2165/00003495-200464170-00002 · Cited by 130
Abraham, J., Bakke, S., Rutt, A., Meadows, B., Merino, M. J., Alexander, R. H., Schrump, D. S., Bartlett, D., Choyke, P. L., Robey, R. W., et al. (2002) · Cancer · doi:10.1002/cncr.10487 · Cited by 129
Helsinki score—a novel model for prediction of metastases in adrenocortical carcinomas
Pennanen, M., Heiskanen, I., Sane, T., Remes, S. M., Mustonen, H. K., Haglund, C. H., & Arola, J. T. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.11.015 · Cited by 128
Boulle, N. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.5.1713 · Cited by 127
Phase I Trial of Cixutumumab Combined with Temsirolimus in Patients with Advanced Cancer
Naing, A., Kurzrock, R., Burger, A. M., Gupta, S. K., Lei, X. J., Busaidy, N. L., Hong, D. S., Chen, H. X., Doyle, L. A., Heilbrun, L. K., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2979 · Cited by 125
Lerário, A. M., Worden, F. P., Ramm, C. A., Hasseltine, E. A., Stadler, W. M., Else, T., Shah, M. H., Agamah, E. S., Rao, K., & Hammer, G. D. (2014) · Hormones and Cancer · doi:10.1007/s12672-014-0182-1 · Cited by 121
Self-citationSangoi, A. R., Fujiwara, M., West, R. B., Montgomery, K. D., Bonventre, J. V., Higgins, J., Rouse, R. V., Gökden, N., & McKenney, J. K. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182152629 · Cited by 121
Adrenocortical Adenoma and Carcinoma: Histopathological and Molecular Comparative Analysis
Stojadinovic, A., Brennan, M. F., Hoos, A., Ömeroğlu, A., Leung, D. H. Y., Dudas, M. E., Nissan, A., Cordon‐Cardo, C., & Ghossein, R. A. (2003) · Modern Pathology · doi:10.1097/01.mp.0000081730.72305.81 · Cited by 117
Association of adrenocortical carcinoma with familial cancer susceptibility syndromes
Else, T. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.12.008 · Cited by 117
Self-citationPathologic Features of Prognostic Significance for Adrenocortical Carcinoma After Curative Resection
Harrison, L. E., Gaudin, P. B., & Brennan, M. F. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.2.181 · Cited by 117
Terzolo, M., Pia, A. R., Berruti, A., Osella, G., Alı̀, A., Carbone, V., Testa, E., Dogliotti, L., & Angeli, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6619 · Cited by 116
Self-citationMackie, G. C., Shulkin, B. L., Ribeiro, R. C., Worden, F. P., Gauger, P. G., Mody, R. J., Connolly, L. P., Kunter, G., Rodriguez-Galindo, C., Wallis, J. W., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2612 · Cited by 115
Surgical management, DNA content, and patient survival in adrenal cortical carcinoma
Lee, J. E., Berger, D. H., El‐Naggar, A. K., Hickey, R. C., Vassilopoulou‐Sellin, R., Gagel, R. F., Burgess, M. A., & Evans, D. B. (1995) · Surgery · doi:10.1016/s0039-6060(05)80119-9 · Cited by 115
Management of adrenal cancer: a 2013 update
Terzolo, M., Daffara, F., Ardito, A., Zaggia, B., Basile, V., Ferrari, L., & Berruti, A. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-013-0049-2 · Cited by 115
Self-citationAnalysis of circulating microRNAs in adrenocortical tumors
Szabó, D. R., Luconi, M., Szabó, P. M., Tóth, M., Szücs, N., Horányi, J., Nagy, Z., Mannelli, M., Patócs, A., Rácz, K., et al. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.148 · Cited by 113
Hines, J. M., Bancos, I., Bancos, C., Singh, R. D., Avula, A. V., Young, W. F., Grebe, S. K., & Singh, R. J. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.271106 · Cited by 111
Henning, J. E. K., Deutschbein, T., Altieri, B., Steinhauer, S., Kircher, S., Sbiera, S., Wild, V., Schlötelburg, W., Kroiß, M., Perotti, P., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01624 · Cited by 111
Self-citationThe VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical Cancer
O'Sullivan, C. C., Edgerly, M., Velarde, M., Wilkerson, J., Venkatesan, A. M., Pittaluga, S., Yang, S. X., Nguyen, D., Balasubramaniam, S., & Fojo, T. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2298 · Cited by 110
Hescot, S., Slama, A., Lombès, A., Paci, A., Remy, H., Leboulleux, S., Chadarévian, R., Trabado, S., Amazit, L., Young, J., et al. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0368 · Cited by 110
Bukowski, R. M., Wolfe, M., Levine, H. S., Crawford, D., Stephens, R. L., Gaynor, E. R., & Harker, W. G. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.1.161 · Cited by 110
Williamson, S. K., Lew, D., Miller, G. J., Balcerzak, S. P., Baker, L. H., & Crawford, E. D. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000301)88:5<1159::aid-cncr28>3.0.co;2-r · Cited by 109
TP53 Germline Mutations in Adult Patients with Adrenocortical Carcinoma
Herrmann, L. J. M., Heinze, B., Fassnacht, M., Willenberg, H. S., Quinkler, M., Reisch, N., Zink, M., Allolio, B., & Hahner, S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1982 · Cited by 109
Komminoth, P., Roth, J., Schröder, S., Saremaslani, P., & Heitz, P. U. (1995) · PubMed · Cited by 109
A 13-steroid serum panel based on LC-MS/MS: use in detection of adrenocortical carcinoma
Taylor, D. R., Ghataore, L., Couchman, L., Vincent, R. P., Whitelaw, B., Lewis, D., Diaz-Cano, S., Galata, G., Schulte, K.-M., Aylwin, S., et al. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.277624 · Cited by 109
Raymond, V. M., Else, T., Everett, J. N., Long, J. M., Gruber, S. B., & Hammer, G. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2198 · Cited by 105
Self-citationRiccardo Autorino, B., Bove, P., SIO, M. D., Miano, R., Micali, S., Cindolo, L., Greco, F., Nicholas, J., Fiori, C., Bianchi, G., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4900-x · Cited by 105
Diagnostic value of urinary steroid profiling in the evaluation of adrenal tumors
Kerkhofs, T. M. A., Kerstens, M. N., Kema, I. P., Willems, T. P., & Haak, H. R. (2015) · Hormones and Cancer · doi:10.1007/s12672-015-0224-3 · Cited by 102
Self-citationAdrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes
Margonis, G. A., Kim, Y., Prescott, J. D., Tran, T. B., Postlewait, L. M., Maithel, S. K., Wang, T. S., Evans, D. B., Hatzaras, I. S., Shenoy, R. S., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4803-x · Cited by 102
Comparison of Two Mitotane Starting Dose Regimens in Patients With Advanced Adrenocortical Carcinoma
Kerkhofs, T. M. A., Baudin, É., Terzolo, M., Allolio, B., Chadarévian, R., Mueller, H. H., Skogseid, B. M., Leboulleux, S., Mantero, F., Haak, H. R., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2281 · Cited by 102
Self-citationKamio, T., Shigematsu, K., Sou, H., Kawai, K., & Tsuchiyama, H. (1990) · Human Pathology · doi:10.1016/0046-8177(90)90227-v · Cited by 102
Habra, M. A., Ejaz, S., Feng, L., Das, P., Deniz, F., Grubbs, E. G., Phan, A., Waguespack, S. G., Ayala-Ramirez, M., Jimenez, C., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2367 · Cited by 101
Operative management for recurrent and metastatic adrenocortical carcinoma
Datrice, N., Langan, R. C., Ripley, R. T., Kemp, C. D., Steinberg, S. M., Wood, B. J., Libutti, S. K., Fojo, T., Schrump, D. S., & Avital, I. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.23015 · Cited by 100
An International Ki67 Reproducibility Study in Adrenal Cortical Carcinoma
Papathomas, T. G., Pucci, E., Giordano, T. J., Lu, H., Duregon, E., Volante, M., Papotti, M. G., Lloyd, R. V., Tischler, A. S., van Nederveen, F. H., et al. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000574 · Cited by 99
Validation of the prognostic role of the “Helsinki Score” in 225 cases of adrenocortical carcinoma
Duregon, E., Cappellesso, R., Maffeis, V., Zaggia, B., Ventura, L., Berruti, A., Terzolo, M., Fassina, A., Volante, M., & Papotti, M. (2017) · Human Pathology · doi:10.1016/j.humpath.2016.09.035 · Cited by 98
Self-citationAdrenocortical carcinoma: effect of hospital volume on patient outcome
Lombardi, C. P., Raffaelli, M., Boniardi, M., Toma, G. D., Marzano, L. A., Miccoli, P., Minni, F., Morino, M., Pelizzo, M. R., Pietrabissa, A., et al. (2011) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-011-0866-8 · Cited by 98
Outcomes of adrenal cortical carcinoma in the United States
Paton, B. L., Novitsky, Y. W., Zerey, M., Harrell, A. G., Norton, H. J., Asbun, H., Kercher, K. W., & Heniford, B. T. (2006) · Surgery · doi:10.1016/j.surg.2006.07.035 · Cited by 97
Jones, R. L., Kim, E. S., Nava-Parada, P., Alam, S. M., Johnson, F. M., Stephens, A. W., Simantov, R., Poondru, S., Gedrich, R., Lippman, S. M., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0265 · Cited by 96
Bates, S. E., Shieh, C.-Y., Mickley, L. A., Dichek, H. L., Gazdar, A. F., Loriaux, D. L., & Fojo, A. T. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-1-18 · Cited by 94
Fragoso, M. C. B. V., Almeida, M. Q., Mazzuco, T. L., Mariani, B. M. P., Brito, L. P., Gonçalves, T. C., Alencar, G. A., Lima, L. D. O., Faria, A. M., Bourdeau, I., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0806 · Cited by 93
Postlewait, L. M., Ethun, C. G., Tran, T. B., Prescott, J. D., Pawlik, T. M., Wang, T. S., Glenn, J. A., Hatzaras, I. S., Shenoy, R. S., Phay, J. E., et al. (2015) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2015.12.013 · Cited by 92
Vanbrabant, T., Fassnacht, M., Assie, G., & Dekkers, O. M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0450 · Cited by 91
Self-citationCytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma
INSERM, A. R. C., Bonacci, R., Gigliotti, A., Baudin, É., Wion-Barbot, N., Emy, P., Bonnay, M., Af, C., Nakib, I., & Schlumberger, M. J. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.530 · Cited by 88
Recommendation for standardized surgical management of primary adrenocortical carcinoma
Gaujoux, S., & Brennan, M. F. (2012) · Surgery · doi:10.1016/j.surg.2011.09.030 · Cited by 87
[131I]Iodometomidate for targeted radionuclide therapy of advanced adrenocortical carcinoma
Hahner, S., Kreissl, M. C., Fassnacht, M., Haenscheid, H., Knoedler, P., Lang, K., Buck, A. K., Reiners, C., Allolio, B., & Schirbel, A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2765 · Cited by 87
Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma
Gonzalez, R. J., Tamm, E. P., Ng, C., Phan, A. T., Vassilopoulou-Sellin, R., Perrier, N. D., Evans, D. B., & Lee, J. E. (2007) · Surgery · doi:10.1016/j.surg.2007.09.006 · Cited by 84
Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade
Miller, B. S., Gauger, P. G., Hammer, G. D., Giordano, T. J., & Doherty, G. M. (2010) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-010-0698-y · Cited by 84
Sabolch, A. N., Else, T., Griffith, K. A., Ben‐Josef, E., Williams, A., Miller, B. S., Worden, F. P., Hammer, G. D., & Jolly, S. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.01.007 · Cited by 83
Self-citationWilliams, A. R., Hammer, G. D., & Else, T. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-1033 · Cited by 83
Self-citation5‐Fluorouracil, doxorubicin, and cisplatin as treatment for adrenal cortical carcinoma
Schlumberger, M. J., Brugières, L., Gicquel, C., Travagli, J., Droz, J., & Parmentier, C. (1991) · Cancer · doi:10.1002/1097-0142(19910615)67:12<2997::aid-cncr2820671211>3.0.co;2-# · Cited by 82
Jensen, J. C. (1991) · Archives of Surgery · doi:10.1001/archsurg.1991.01410280059008 · Cited by 81
Pan, C., Chen, P. C.-H., Tsay, S., et al. (2005) · Applied immunohistochemistry & molecular morphology · doi:10.1097/01.pai.0000146525.72531.19 · Cited by 80
DNA methylation is an independent prognostic marker of survival in adrenocortical cancer
Jouinot, A., Assié, G., Libé, R., Faßnacht, M., Papathomas, T. G., Barreau, O., Villéon, B. D. L., Faillot, S., Hamzaoui, N., Néou, M., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3205 · Cited by 80
Wängberg, B., Khorram‐Manesh, A., Jansson, S., Nilsson, B., Nilsson, O., Jakobsson, C. E., Lindstedt, S., Odén, A., & Ahlman, H. K. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0190 · Cited by 78
Guérin, C., Pattou, F. N., Brunaud, L., Lifante, J., Mirallié, É., Haissaguerre, M., Huglo, D. G., Olivier, P., Houzard, C., Ansquer, C., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00254 · Cited by 78
Decker, R. A., Elson, P. J., Hogan, T. F., Citrin, D. L., Westring, D. W., Banerjee, T. K., Gilchrist, K. W., & Horton, J. (1991) · PubMed · Cited by 77
FDG PET in the Management of Patients with Adrenal Masses and Adrenocortical Carcinoma
Deandreis, D., Leboulleux, S., Caramella, C., Schlumberger, M. J., & Baudin, É. (2011) · Hormones and Cancer · doi:10.1007/s12672-011-0091-5 · Cited by 77
Kim, S.-J., Lee, S.-W., Pak, K., Kim, I.-J., & Kim, K. (2018) · The British Journal of Radiology · doi:10.1259/bjr.20170520 · Cited by 76
Eller-Vainicher, C., Morelli, V., Salcuni, A. S., Battista, C., Torlontano, M., Coletti, F., Iorio, L., Cairoli, E., Beck-Peccoz, P., Arosio, M., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0602 · Cited by 73
Resection of Adrenocortical Carcinoma Liver Metastasis: Is it Justified?
Gaujoux, S., Al‐Ahmadie, H. A., Allen, P. J., Gönen, M., Shia, J., D'Angelica, M. I., DeMatteo, R. P., Fong, Y., Blumgart, L. H., & Jarnagin, W. R. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2358-7 · Cited by 73
Moolenaar, A. J., van Slooten, H., van Seters, A. P., & Smeenk, D. (1981) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00258213 · Cited by 72
Oncocytic Adrenocortical Tumors: Diagnostic Algorithm and Mitochondrial DNA Profile in 27 Cases
Duregon, E., Volante, M., Cappia, S., Cuccurullo, A., Bisceglia, M., Wong, D., Spagnolo, D. V., Szpak‐Ulczok, S., Bollito, E., Daffara, F., et al. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31822da401 · Cited by 72
Self-citationBorderline Resectable Adrenal Cortical Carcinoma: A Potential Role for Preoperative Chemotherapy
Bednarski, B. K., Habra, M. A., Phan, A. T., Milton, D. R., Wood, C. G., Vauthey, N., Evans, D. B., Katz, M. H. G., Ng, C. S., Perrier, N. D., et al. (2014) · World Journal of Surgery · doi:10.1007/s00268-014-2484-4 · Cited by 72
Perge, P., Butz, H., Pezzani, R., Bancos, I., Nagy, Z., Pálóczi, K., Nyírő, G., Decmann, Á., Pap, E., Luconi, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05777-0 · Cited by 71
Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm
Arola, J. T., Liu, J., Heikkilä, P., Ilvesmäki, V., Salmenkivi, K., Voutilainen, R., & Kahri, A. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1650223 · Cited by 70
Mauclère-Denost, S., Leboulleux, S., Borget, I., Paci, A., Young, J., Ghuzlan, A. A., Deandreis, D., Drouard, L., Tabarin, A., Chanson, P., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0557 · Cited by 70
Romeo, V., Maurea, S., Cuocolo, R., Petretta, M., Mainenti, P. P., Verde, F., Coppola, M., Dell'Aversana, S., & Brunetti, A. (2018) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25954 · Cited by 69
Ronchi, C. L., Sbiera, S., Kraus, L., Wortmann, S., Johanssen, S., Adam, P., Willenberg, H. S., Hahner, S., Allolio, B., & Faßnacht, M. (2009) · Endocrine Related Cancer · doi:10.1677/erc-08-0224 · Cited by 69
Volante, M., Terzolo, M., Fassnacht, M., Rapa, I., Germano, A., Sbiera, S., Daffara, F., Sperone, P., Scagliotti, G., Allolio, B., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2692 · Cited by 69
Self-citationRonchi, C. L., Sbiera, S., Leich, E., Henzel, K., Rosenwald, A., Allolio, B., & Fassnacht, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073959 · Cited by 68
Self-citationKerkhofs, T. M. A., Verhoeven, R. H. A., Bonjer, H. J., van Dijkum, E. J. M. N., Vriens, M. R., de Vries, J., van Eijck, C. H. J., Bonsing, B. A., van de Poll-Franse, L. V., Haak, H. R., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0142 · Cited by 67
Self-citationCurative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence
Amini, N., Margonis, G. A., Kim, Y., Tran, T. B., Postlewait, L. M., Maithel, S. K., Wang, T. S., Evans, D. B., Hatzaras, I. S., Shenoy, R. S., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4810-y · Cited by 64
Adjunctive treatment of adrenocortical carcinoma
Terzolo, M., & Berruti, A. (2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282fdf4c0 · Cited by 64
Self-citationMalandrino, P., Ghuzlan, A. A., Castaing, M., Young, J., Caillou, B., Travagli, J., Elias, D. M., de Baère, T., Dromain, C., Paci, A., et al. (2010) · Endocrine Related Cancer · doi:10.1677/erc-09-0341 · Cited by 64
Stoffel, E. M., Mangu, P. B., & Limburg, P. J. (2015) · Journal of Oncology Practice · doi:10.1200/jop.2015.003665 · Cited by 64
Wang, C., Sun, Y., Wu, H., Zhao, D., & Chen, J. (2013) · Histopathology · doi:10.1111/his.12283 · Cited by 63
Kemp, C. D., Ripley, R. T., Mathur, A., Steinberg, S. M., Nguyen, D. M., Fojo, T., & Schrump, D. S. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2011.05.013 · Cited by 63
Liver resection and ablation for metastatic adrenocortical carcinoma
Ripley, R. T., Kemp, C. D., Davis, J. L., Langan, R. C., Royal, R. E., Libutti, S. K., Steinberg, S. M., Wood, B. J., Kammula, U. S., Fojo, T., et al. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1564-z · Cited by 62
Imaging of incidentally discovered adrenal masses
Peppercorn, P. D., Grossman, A. B., & Reznek, R. H. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00475.x · Cited by 62
Adjuvant Mitotane for Adrenocortical Cancer—A Recurring Controversy
Huang, H., & Fojo, T. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0579 · Cited by 62
ENDOCRINE TUMOURS: The genomics of adrenocortical tumors
Faillot, S., & Assié, G. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1118 · Cited by 62
Cazejust, J., de Baère, T., Auperin, A., Deschamps, F., Hechelhammer, L., Abdel-Rehim, M., Schlumberger, M. J., Leboulleux, S., & Baudin, É. (2010) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2010.05.020 · Cited by 61
Gallagher, S. F., Wahi, M. M., Haines, K., Baksh, K. A., Enriquez, J., Lee, T.-M., Murr, M. M., & Fabri, P. J. (2007) · Surgery · doi:10.1016/j.surg.2007.09.024 · Cited by 61
Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence
Glover, A. R., Zhao, J., Ip, J. C. Y., Lee, J. C., Robinson, B. G., Gill, A. J., Soon, P., & Sidhu, S. B. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0457 · Cited by 61
Tissier, F., Aubert, S., Leteurtre, E., Ghuzlan, A. A., Patey, M., Decaussin‐Petrucci, M., Doucet, L., Gobet, F., Hoang, C., Mazerolles, C., et al. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31825a6308 · Cited by 61
Cited by
Fassnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J., Pelsma, I., Marina, L., Lorenz, K., Bancos, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad066 · Cited by 786
Self-citationNeuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Shah, M. H., Goldner, W. S., Benson, A. B., Bergsland, E., Blaszkowsky, L. S., Brock, P., Chan, J., Das, S., Dickson, P. V., Fanta, P., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0032 · Cited by 619
Fassnacht, M., Assie, G., Baudin, E., Eisenhofer, G., de la Fouchardiere, C., Haak, H. R., de Krijger, R., Porpiglia, F., Terzolo, M., & Berruti, A. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.08.2099 · Cited by 436
Self-citationOverview of the 2022 WHO Classification of Adrenal Cortical Tumors
Mete, O., Erickson, L. A., Juhlin, C. C., de Krijger, R. R., Sasano, H., Volante, M., & Papotti, M. G. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09710-8 · Cited by 343
Self-citationReincke, M., & Fleseriu, M. (2023) · JAMA · doi:10.1001/jama.2023.11305 · Cited by 256
Metadata
- Authors
- Fassnacht, M., Dekkers, O. M., Else, T., Baudin, E., Berruti, A., de Krijger, R. R., Haak, H. R., Mihai, R., Assie, G., & Terzolo, M.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-10
- Volume
- 179
- Issue
- 4
- Pages
- G1-G46
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2883682970
- Cited by
- 961
- References
- 306
- FWCI
- 76.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.